These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9679855

  • 1. Modified antigenic reactivity of anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: conversion with immunotherapy and relation to subclass expression.
    Michils A, Mairesse M, Ledent C, Gossart B, Baldassarre S, Duchateau J.
    J Allergy Clin Immunol; 1998 Jul; 102(1):118-26. PubMed ID: 9679855
    [Abstract] [Full Text] [Related]

  • 2. Early effect of ultrarush venom immunotherapy on the IgG antibody response.
    Michils A, Baldassarre S, Ledent C, Mairesse M, Gossart B, Duchateau J.
    Allergy; 2000 May; 55(5):455-62. PubMed ID: 10843426
    [Abstract] [Full Text] [Related]

  • 3. Wasp venom immunotherapy changes IgG antibody specificity.
    Michils A, Ledent C, Mairesse M, Gossart B, Duchateau J.
    Clin Exp Allergy; 1997 Sep; 27(9):1036-42. PubMed ID: 9678835
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM, MacKenzie-Mills M, Harries MG, Youlten LJ, Lessof MH.
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [Abstract] [Full Text] [Related]

  • 5. Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model.
    Michils A, Vervier I, Choufani G, Gossart B, Duchateau J.
    Clin Exp Allergy; 1999 Jun; 29(6):832-9. PubMed ID: 10336601
    [Abstract] [Full Text] [Related]

  • 6. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
    Urbanek R, Kemeny DM, Richards D.
    Clin Allergy; 1986 Jul; 16(4):317-22. PubMed ID: 3742787
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
    Kemeny DM, Harries MG, Youlten LJ, Mackenzie-Mills M, Lessof MH.
    J Allergy Clin Immunol; 1983 May; 71(5):505-14. PubMed ID: 6601672
    [Abstract] [Full Text] [Related]

  • 8. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.
    Djurup R, Malling HJ, Søndergaard I, Weeke B.
    J Allergy Clin Immunol; 1985 Jul; 76(1):46-55. PubMed ID: 4008813
    [Abstract] [Full Text] [Related]

  • 9. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy.
    Devey ME, Lee SR, Richards D, Kemeny DM.
    J Allergy Clin Immunol; 1989 Sep; 84(3):326-30. PubMed ID: 2778238
    [Abstract] [Full Text] [Related]

  • 10. Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by competitive inhibition in ELISA.
    Rieben R, Blaser K.
    J Immunol Methods; 1989 Apr 21; 119(1):1-8. PubMed ID: 2708823
    [Abstract] [Full Text] [Related]

  • 11. Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children.
    Varga EM, Francis JN, Zach MS, Klunker S, Aberer W, Durham SR.
    Clin Exp Allergy; 2009 Sep 21; 39(9):1353-7. PubMed ID: 19538349
    [Abstract] [Full Text] [Related]

  • 12. The immune response to bee venom. Comparison of the antibody response to phospholipase A2 with the response to inhalant antigens.
    Kemeny DM, Miyachi S, Platts-Mills TA, Wilkins S, Lessof MH.
    Int Arch Allergy Appl Immunol; 1982 Sep 21; 68(3):268-74. PubMed ID: 7085123
    [Abstract] [Full Text] [Related]

  • 13. Immune response to bee venom. II. Quantitation of the absolute amounts of IgE and IgG antibodies by saturation analysis.
    Kemeny DM, Lessof MH.
    Int Arch Allergy Appl Immunol; 1987 Sep 21; 83(2):113-20. PubMed ID: 3583409
    [Abstract] [Full Text] [Related]

  • 14. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.
    Müller U, Helbling A, Bischof M.
    Allergy; 1989 Aug 21; 44(6):412-8. PubMed ID: 2802114
    [Abstract] [Full Text] [Related]

  • 15. A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom.
    Wilson AB, Deighton J, Lachmann PJ, Ewan PW.
    Allergy; 1994 Apr 21; 49(4):272-80. PubMed ID: 8037359
    [Abstract] [Full Text] [Related]

  • 16. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K.
    J Allergy Clin Immunol; 1998 Jun 21; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [Abstract] [Full Text] [Related]

  • 17. Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.
    Kämmerer R, Chvatchko Y, Kettner A, Dufour N, Corradin G, Spertini F.
    J Allergy Clin Immunol; 1997 Jul 21; 100(1):96-103. PubMed ID: 9257793
    [Abstract] [Full Text] [Related]

  • 18. Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.
    Wetterwald A, Skvaril F, Müller U, Blaser K.
    Int Arch Allergy Appl Immunol; 1985 Jul 21; 77(1-2):195-7. PubMed ID: 4008074
    [Abstract] [Full Text] [Related]

  • 19. Honey bee venom specific immunoglobulin G4 in honey bee sting allergic patients and bee keepers.
    Cheung NK, Blessing-Moore J, Reid MJ, Yang G.
    Ann Allergy; 1983 Mar 21; 50(3):155-60. PubMed ID: 6600888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.